QT Investigations
QT investigations are a crucial component of the clinical development program, addressing aspects such as clinical safety concerns, drug studies, and QT prolongation risk assessment. With over 35 years of experience, Biotrial is a trusted partner in providing comprehensive support at every stage of a drug trial, from design and planning to data analysis and reporting.
Whether this means including a QT investigation component within a phase I program, performing a dedicated Thorough QT (TQT) trial, or implementing further measures within various Clinical Pharmacology or phase II-III trials, Biotrial’s Core Lab offers the required expertise.